Sunitinib

Results: 221



#Item
41New target: FGFR & c-MET Laurence Albiges Gustave Roussy Institute, Dana-Farber Cancer Institute  New target : FGFR, c-MET

New target: FGFR & c-MET Laurence Albiges Gustave Roussy Institute, Dana-Farber Cancer Institute New target : FGFR, c-MET

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:47
42New Targets to Reverse VEGF Resistance Prof. Eric Raymond, MD, PhD Head of Medical Oncology UNIL-CHUV – Lausanne - Switzerland

New Targets to Reverse VEGF Resistance Prof. Eric Raymond, MD, PhD Head of Medical Oncology UNIL-CHUV – Lausanne - Switzerland

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:42
43Negative Trials in RCC: Where Did We Go Wrong? Can We Do Better? 9th European Kidney Cancer Symposium, Dublin, April 2014 Tim Eisen

Negative Trials in RCC: Where Did We Go Wrong? Can We Do Better? 9th European Kidney Cancer Symposium, Dublin, April 2014 Tim Eisen

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:16:02
44Challenges for Patients on Long Term Systemic Therapy Prof. Cezary Szczylik, MD PhD Department of Oncology Military Institute of Medicine

Challenges for Patients on Long Term Systemic Therapy Prof. Cezary Szczylik, MD PhD Department of Oncology Military Institute of Medicine

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:25:25
45Have Results of Recent Randomized Trials Changed the Role of mTOR Inhibitors? Bernard Escudier Institut Gustave Roussy

Have Results of Recent Randomized Trials Changed the Role of mTOR Inhibitors? Bernard Escudier Institut Gustave Roussy

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2015-05-04 13:05:46
46Late-Breaking Abstracts 2015 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer® Opening Scientific Session Saturday, March 28, 2015 Moderators: Uziel Beller, MD, Shaare Zedek Medical Center, Jerusalem,

Late-Breaking Abstracts 2015 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer® Opening Scientific Session Saturday, March 28, 2015 Moderators: Uziel Beller, MD, Shaare Zedek Medical Center, Jerusalem,

Add to Reading List

Source URL: www.sgo.org

Language: English - Date: 2015-03-30 08:47:42
47Do we need to pay more attention to bone metastases? Lisa Pickering Consultant Medical Oncologist St. George’s and Royal Marsden Hospitals London, UK

Do we need to pay more attention to bone metastases? Lisa Pickering Consultant Medical Oncologist St. George’s and Royal Marsden Hospitals London, UK

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:24:32
48Optimal systemic therapy in the setting of hepatic and renal dysfuction. Professor Thomas Powles Head of Renal Cancer London Cancer

Optimal systemic therapy in the setting of hepatic and renal dysfuction. Professor Thomas Powles Head of Renal Cancer London Cancer

Add to Reading List

Source URL: www.euikcs.com

Language: English - Date: 2014-05-13 15:20:07
49

PDF Document

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2012-08-31 14:12:03
50Microsoft WordSorafenib NEXAVAR BayerPSD FINAL.doc

Microsoft WordSorafenib NEXAVAR BayerPSD FINAL.doc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2014-10-01 21:56:23